PubRank

J R Ortaldo

Author PubWeight™ 206.44‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Characteristics of human large granular lymphocytes and relationship to natural killer and K cells. J Exp Med 1981 5.76
2 Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993 4.94
3 Natural killer cells: their roles in defenses against disease. Science 1981 4.59
4 Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2. Nature 1994 3.31
5 Natural killer cells: characteristics and regulation of activity. Immunol Rev 1979 3.14
6 Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects. J Immunol 1984 3.07
7 Determination of surface antigens on highly purified human NK cells by flow cytometry with monoclonal antibodies. J Immunol 1981 3.05
8 Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity. Nature 1979 2.94
9 Lymphokine-activated killer cells. Analysis of progenitors and effectors. J Exp Med 1986 2.70
10 Heterogeneity of natural killer cells. Annu Rev Immunol 1984 2.59
11 Alpha and beta chemokines induce NK cell migration and enhance NK-mediated cytolysis. J Immunol 1995 2.52
12 Interleukin 12 induces tyrosine phosphorylation and activation of STAT4 in human lymphocytes. Proc Natl Acad Sci U S A 1995 2.52
13 Tyrosine phosphorylation and activation of STAT5, STAT3, and Janus kinases by interleukins 2 and 15. Proc Natl Acad Sci U S A 1995 2.19
14 DAP12-mediated signal transduction in natural killer cells. A dominant role for the Syk protein-tyrosine kinase. J Biol Chem 1998 2.10
15 Natural killer-sensitive targets stimulate production of TNF-alpha but not TNF-beta (lymphotoxin) by highly purified human peripheral blood large granular lymphocytes. J Immunol 1986 2.05
16 Cytotoxic reactivity of human lymphocytes cultured in vitro. J Immunol 1977 1.88
17 Molecular cloning of L-JAK, a Janus family protein-tyrosine kinase expressed in natural killer cells and activated leukocytes. Proc Natl Acad Sci U S A 1994 1.84
18 Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med 1995 1.78
19 Mechanism of cytotoxicity by natural killer (NK) cells. Annu Rev Immunol 1986 1.72
20 Beta chemokines costimulate lymphocyte cytolysis, proliferation, and lymphokine production. J Leukoc Biol 1996 1.70
21 In vivo administration of IL-18 can induce IgE production through Th2 cytokine induction and up-regulation of CD40 ligand (CD154) expression on CD4+ T cells. Eur J Immunol 2000 1.57
22 Natural killer activity in the rat. II. Analysis of surface antigens on LGL by flow cytometry. J Immunol 1981 1.51
23 One-signal requirement for interferon-gamma production by human large granular lymphocytes. J Immunol 1987 1.49
24 Characterization of the family of dimers associated with Fc receptors (Fc epsilon RI and Fc gamma RIII). J Immunol 1991 1.48
25 Augmentation of organ-associated natural killer activity by biological response modifiers. Isolation and characterization of large granular lymphocytes from the liver. J Exp Med 1984 1.41
26 Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. J Immunol 1985 1.40
27 Mediation of mouse natural cytotoxic activity by tumour necrosis factor. Nature 1986 1.39
28 Engagement of the natural killer cell IgG Fc receptor results in tyrosine phosphorylation of the zeta chain. Proc Natl Acad Sci U S A 1991 1.39
29 The Ly-49D receptor activates murine natural killer cells. J Exp Med 1996 1.39
30 Isolation of human and rat natural killer cells. J Immunol Methods 1982 1.39
31 Analysis of effector mechanisms against HTLV-I- and HTLV-III/LAV-infected lymphoid cells. J Immunol 1986 1.37
32 Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells. J Immunol 1999 1.37
33 Specificity of natural cytotoxic reactivity of normal human lymphocytes against a myeloid leukemia cell line. J Natl Cancer Inst 1977 1.36
34 Cloning and functional characteristics of murine large granular lymphocyte-1: a member of the Ly-49 gene family (Ly-49G2) J Exp Med 1995 1.35
35 Analysis by a single cell cytotoxicity assay of natural killer (NK) cells frequencies among human large granular lymphocytes and of the effects of interferon on their activity. J Immunol 1982 1.34
36 IL-2 regulation of tyrosine kinase activity is mediated through the p70-75 beta-subunit of the IL-2 receptor. J Immunol 1989 1.33
37 Cytotoxicity by cultured human lymphocytes: characteristics of effector cells and specificity of cytotoxicity. J Immunol 1979 1.32
38 Selective depletion of human natural killer cells on monolayers of target cells. J Immunol 1980 1.29
39 Mouse Ly-49D recognizes H-2Dd and activates natural killer cell cytotoxicity. J Exp Med 1999 1.27
40 The nuclear factor YY1 suppresses the human gamma interferon promoter through two mechanisms: inhibition of AP1 binding and activation of a silencer element. Mol Cell Biol 1996 1.26
41 The ever-expanding Ly49 gene family: repertoire and signaling. Immunol Rev 2001 1.26
42 A species of human alpha interferon that lacks the ability to boost human natural killer activity. Proc Natl Acad Sci U S A 1984 1.23
43 Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. J Exp Med 1990 1.22
44 Expression and role of p75 interleukin 2 receptor on human monocytes. J Exp Med 1990 1.19
45 Human large granular lymphocytes are potent producers of interleukin-1. Nature 1984 1.18
46 IL-8 gene expression and production in human peripheral blood lymphocyte subsets. J Immunol 1991 1.18
47 A cyclophilin-related protein involved in the function of natural killer cells. Proc Natl Acad Sci U S A 1993 1.17
48 Regulation of lymphokine-activated killer activity and pore-forming protein gene expression in human peripheral blood CD8+ T lymphocytes. Inhibition by transforming growth factor-beta. J Immunol 1991 1.17
49 Analysis of effector cells in human antibody-dependent cellular cytotoxicity with murine monoclonal antibodies. J Immunol 1987 1.17
50 A role for protein tyrosine kinase activity in natural cytotoxicity as well as antibody-dependent cellular cytotoxicity. Effects of herbimycin A. J Immunol 1992 1.17
51 Role of organ-associated NK cells in decreased formation of experimental metastases in lung and liver. J Immunol 1985 1.17
52 Class I MHC-binding characteristics of the 129/J Ly49 repertoire. J Immunol 2001 1.15
53 Transformation of owl monkey T cells in vitro with Herpesvirus saimiri. Proc Natl Acad Sci U S A 1984 1.14
54 Analysis of T cell receptors in highly purified rat and human large granular lymphocytes (LGL): lack of functional 1.3 kb beta-chain mRNA. J Immunol 1986 1.14
55 Effects of metabolic inhibitors on spontaneous and interferon-boosted human natural killer cell activity. J Immunol 1980 1.12
56 Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes. Int J Cancer 1983 1.12
57 NK cell infiltration into lung, liver, and subcutaneous B16 melanoma is mediated by VCAM-1/VLA-4 interaction. J Immunol 1996 1.09
58 IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells. J Immunol 1990 1.09
59 Tolerance and alloreactivity of the Ly49D subset of murine NK cells. J Immunol 1999 1.09
60 Cellular and molecular mechanisms of IFN-gamma production induced by IL-2 and IL-12 in a human NK cell line. J Leukoc Biol 1995 1.09
61 Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes. Cell Immunol 1982 1.08
62 Induction of DAP12 phosphorylation, calcium mobilization, and cytokine secretion by Ly49H. J Leukoc Biol 1999 1.08
63 Characterization of a suppressor T-cell chronic lymphocytic leukemia with ADCC but not NK activity. Blood 1980 1.08
64 IL-13 production by NK cells: IL-13-producing NK and T cells are present in vivo in the absence of IFN-gamma. J Immunol 1999 1.07
65 Role of a STAT binding site in the regulation of the human perforin promoter. J Immunol 1999 1.07
66 Characterization of an associated 16-kDa tyrosine phosphoprotein required for Ly-49D signal transduction. J Immunol 1998 1.06
67 The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol 1999 1.05
68 The natural killer gene complex genetic locus Chok encodes Ly-49D, a target recognition receptor that activates natural killing. Proc Natl Acad Sci U S A 1999 1.05
69 Characteristics of human NK clones: target specificity and phenotype. J Immunol 1984 1.03
70 Characterization of a silencer regulatory element in the human interferon-gamma promoter. J Biol Chem 1994 1.02
71 Differential regulation of the Janus kinase-STAT pathway and biologic function of IL-13 in primary human NK and T cells: a comparative study with IL-4. J Immunol 1998 1.02
72 Augmentation of mouse liver-associated natural killer activity by biologic response modifiers occurs largely via rapid recruitment of large granular lymphocytes from the bone marrow. J Immunol 1989 1.02
73 Bone marrow and thymus expression of interferon-gamma results in severe B-cell lineage reduction, T-cell lineage alterations, and hematopoietic progenitor deficiencies. Blood 1997 1.00
74 Flavone acetic acid directly induces expression of cytokine genes in mouse splenic leukocytes but not in human peripheral blood leukocytes. Cancer Res 1991 0.98
75 Cultures of purified human natural killer cells: growth in the presence of interleukin 2. Cell Immunol 1982 0.98
76 Regulation of local host-mediated anti-tumor mechanisms by cytokines: direct and indirect effects on leukocyte recruitment and angiogenesis. Am J Pathol 1997 0.98
77 Modulation of fetal antigen(s) in mouse leukemia cells. Cancer Res 1974 0.98
78 Depression of natural killer cytotoxicity after in vivo administration of recombinant leukocyte interferon. J Immunol 1983 0.97
79 Interaction of Ly-49D+ NK cells with H-2Dd target cells leads to Dap-12 phosphorylation and IFN-gamma secretion. J Immunol 2000 0.97
80 Engraftment and activity of anti-CD3-activated human peripheral blood lymphocytes transferred into mice with severe combined immune deficiency. J Immunol 1993 0.97
81 Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets. J Immunol 1998 0.96
82 Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity. Cancer Treat Rep 1978 0.96
83 Mechanism of target cell recognition by natural killer cells: characterization of a novel triggering molecule restricted to CD3- large granular lymphocytes. J Exp Med 1991 0.96
84 Human B cell activation by autologous NK cells is regulated by CD40-CD40 ligand interaction: role of memory B cells and CD5+ B cells. J Immunol 2001 0.96
85 Proliferation of human peripheral blood lymphocytes induced by recombinant human interleukin 2: contribution of large granular lymphocytes and T lymphocytes. Cell Immunol 1986 0.96
86 Cryopreservation of human lymphocyte function as measured by in vitro assays. Int J Cancer 1976 0.95
87 Characterization of cytokine differential induction of STAT complexes in primary human T and NK cells. J Leukoc Biol 1998 0.94
88 Subsets of human large granular lymphocytes (LGL) exhibit accessory cell functions. J Immunol 1985 0.93
89 Regulation of JAK3 expression and activation in human B cells and B cell malignancies. J Immunol 1995 0.93
90 Cytotoxicity inhibition assay: cryopreservation and standardization: brief communication. J Natl Cancer Inst 1977 0.92
91 Standardization of the chromium-51 release, cell-mediated cytotoxicity assay: cryopreservation of mouse effector and target cells. J Natl Cancer Inst 1977 0.92
92 IFN-gamma treatment of K562 cells inhibits natural killer cell triggering and decreases the susceptibility to lysis by cytoplasmic granules from large granular lymphocytes. J Immunol 1988 0.92
93 Inhibition of human natural killer cell reactivity by exogenous adenosine 5'-triphosphate. J Immunol 1984 0.92
94 IL-7 regulation of cytotoxic lymphocytes: pore-forming protein gene expression, interferon-gamma production, and cytotoxicity of human peripheral blood lymphocytes subsets. Cell Immunol 1991 0.92
95 Deficient natural killer cell (NK) activity and macrophage functioning in schizophrenic patients. J Neural Transm 1983 0.91
96 Production of multiple cytokines by clones of human large granular lymphocytes. Cancer Immunol Immunother 1985 0.91
97 Human large granular lymphocytes: spontaneous and interferon-boosted NK activity against adherent and nonadherent tumor cell lines. J Immunol 1981 0.91
98 Identification of a DNA binding site for the nuclear factor YY1 in the human GM-CSF core promoter. Nucleic Acids Res 1994 0.90
99 Molecular cloning of lsk, a carboxyl-terminal src kinase (csk) related gene, expressed in leukocytes. Oncogene 1994 0.90
100 Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin. J Immunol 1986 0.90
101 Synergistic effects of in vivo depletion of Ly-49A and Ly-49G2 natural killer cell subsets in the rejection of H2(b) bone marrow cell allografts. Blood 2000 0.90
102 In vivo passive sensitization of normal rabbit leukocytes with sera demonstrating homocytotropic antibody activity. Int Arch Allergy Appl Immunol 1971 0.90
103 Comparison of lymphokine secretion and mRNA expression in the CD45RA+ and CD45RO+ subsets of human peripheral blood CD4+ and CD8+ lymphocytes. Eur J Immunol 1995 0.90
104 Role of interferon in regulation of cytotoxicity by natural killer cells and macrophages. Ann N Y Acad Sci 1980 0.89
105 Direct comparison of three isotopic release microtoxicity assays as measures of cell-mediated immunity to Gross virus-induced lymphomas in rats. J Natl Cancer Inst 1977 0.89
106 Differential tyrosine phosphorylation of inhibitory versus activating Ly-49 receptor proteins and their recruitment of SHP-1 phosphatase. J Immunol 1997 0.89
107 Natural killer (NK) cell subsets in the mouse. NK-1.1+/LGL-1+ cells restricted to lysing NK targets, whereas NK-1.1+/LGL-1- cells generate lymphokine-activated killer cells. J Immunol 1990 0.88
108 Regulation of human natural killer cell activity by interferon-gamma: lack of a role in interleukin 2-mediated augmentation. J Immunol 1986 0.88
109 Augmentation of human K-cell activity with interferon. Scand J Immunol 1980 0.88
110 Interferon and prostaglandins: effects on human natural and lectin-induced cytotoxicity. J Natl Cancer Inst 1982 0.86
111 Cloning and characterization of a novel activating Ly49 closely related to Ly49A. J Immunol 1999 0.86
112 Recruitment of hepatic NK cells by IL-12 is dependent on IFN-gamma and VCAM-1 and is rapidly down-regulated by a mechanism involving T cells and expression of Fas. J Immunol 1998 0.86
113 Ly49 C/I-dependent NKT cell-derived IL-10 is required for corneal graft survival and peripheral tolerance. J Leukoc Biol 2008 0.86
114 The antineoplastic agent bryostatin-1 induces proinflammatory cytokine production in human monocytes: synergy with interleukin-2 and modulation of interleukin-2Rgamma chain expression. Blood 1997 0.85
115 Studies of human natural killer cytotoxic factor (NKCF): characterization and analysis of its mode of action. Adv Exp Med Biol 1985 0.85
116 Identification of the Ly49L protein: evidence for activating counterparts to inhibitory Ly49 proteins. J Leukoc Biol 2000 0.85
117 Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. J Clin Invest 1993 0.85
118 Expression of the NK-TR gene is required for NK-like activity in human T cells. J Immunol 1994 0.85
119 IL-4 and IL-13 induce Lsk, a Csk-like tyrosine kinase, in human monocytes. J Exp Med 1994 0.85
120 Adoptive cellular immunotherapy of human ovarian carcinoma xenografts in nude mice. Cancer Res 1986 0.84
121 The virus-specific and allospecific cytotoxic T-lymphocyte response to lymphocytic choriomeningitis virus is modified in a subpopulation of CD8(+) T cells coexpressing the inhibitory major histocompatibility complex class I receptor Ly49G2. J Virol 2000 0.84
122 Cryopreservation of human mononuclear cells for quality control in clinical immunology. I. Correlations in recovery of K- and NK-cell functions, surface markers, and morphology. J Clin Immunol 1982 0.84
123 Ly-49 G2+ NK cells are responsible for mediating the rejection of H-2b bone marrow allografts in mice. Int Immunol 1996 0.84
124 Relationship of mouse natural killer cells to mouse natural cytotoxic cells: effector cells and possible mechanism of action. Immunol Res 1986 0.84
125 Natural killer activity: definition of a function rather than a cell type. J Immunol 1987 0.83
126 Augmentation of natural and antibody-dependent cell-mediated cytotoxicity by pure human leukocyte interferon. J Clin Immunol 1981 0.83
127 Protective effects of interferon in mice previously exposed to lethal irradiation. Radiat Res 1980 0.83
128 Noncytotoxic functions of natural killer (NK) cells: large granular lymphocytes (LGL) produce a B cell growth factor (BCGF). J Immunol 1985 0.83
129 Changes in number and density of large granular lymphocytes upon in vivo augmentation of mouse natural killer activity. J Immunol 1985 0.83
130 Regulation of human large granular lymphocyte and T cell growth and function by recombinant interleukin 2: induction of interleukin 2 receptor and promotion of growth of cells with enhanced cytotoxicity. J Leukoc Biol 1987 0.83
131 LGL-1: a potential triggering molecule on murine NK cells. J Leukoc Biol 1994 0.82
132 Multiple cytolytic mechanisms displayed by activated human peripheral blood T cell subsets. J Immunol 1992 0.82
133 Expression of IFN-alpha and IFN-gamma receptors on normal human small resting T lymphocytes and large granular lymphocytes. J Immunol 1986 0.82
134 Increased proliferation, cytotoxicity, and gene expression after stimulation of human peripheral blood T lymphocytes through a surface ganglioside (GD3) J Immunol 1994 0.82
135 Regulation of NK cells through the 80-kDa TNFR (CD120b). J Leukoc Biol 1995 0.82
136 Brief communication: technical modifications of the human agarose microdroplet leukocyte migration inhibition assay. J Immunol Methods 1978 0.82
137 Immune response to Gross virus-induced lymphoma: cryopreservation of functional activity of rat lymphocytes and tumor cells. Cell Immunol 1976 0.82
138 Comparison of natural killer and natural cytotoxic cells: characteristics, regulation, and mechanism of action. Pathol Immunopathol Res 1986 0.81
139 Activation of peripheral large granular lymphocytes with the serine/threonine phosphatase inhibitor, okadaic acid. Eur J Immunol 1994 0.81
140 Role of CD2 in regulation of CD3- LGL function. Eur Cytokine Netw 1991 0.81
141 IL-4 and IL-13 have overlapping but distinct effects on HIV production in monocytes. J Leukoc Biol 1994 0.81
142 Expression of fetal antigens and tumor-specific antigens in SV40-transformed cells. I. Serological analysis of the antigenic specificities. Int J Cancer 1973 0.81
143 IL-2 signaling in human monocytes involves the phosphorylation and activation of p59hck. J Immunol 2000 0.80
144 Effects of recombinant and hybrid recombinant human leukocyte interferons on cytotoxic activity of natural killer cells. J Biol Chem 1983 0.80
145 Cytotoxicity from cultured cells: analysis of precursors involved in generation of human cells mediating natural and antibody-dependent cell-mediated cytotoxicity. Cell Immunol 1979 0.80
146 Enhanced lymphokine production and lymphokine receptor expression in multiple antibody-stimulated human CD4+ peripheral blood lymphocytes. J Immunol 1992 0.80
147 Natural cytotoxic reactivity of rat lymphocytes against gross virus-induced tumor cell lines as measured by [125I]iododeoxyuridine and tritiated proline microcytotoxicity assays. Cancer Res 1977 0.80
148 Binding of human alpha-interferons to natural killer cells. J Interferon Res 1986 0.80
149 Cultures of human natural killer cells (large granular lymphocytes) and T cells in the presence of interleukin-2-containing conditioned medium. J Reticuloendothel Soc 1983 0.80
150 Analysis of the methylation state of the T cell receptor beta chain gene in T cells and large granular lymphocytes. J Biol Chem 1989 0.79
151 Inhibition of activity of human NK and K cells by simple sugars: discrimination between binding and postbinding events. Clin Immunol Immunopathol 1984 0.79
152 Comparison of the effect of IL-2 and IL-6 on the lytic activity of purified human peripheral blood large granular lymphocytes. J Immunol 1991 0.79
153 Islet cells but not thyrocytes are susceptible to lysis by NK cells. J Autoimmun 1991 0.79
154 Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerations. J Natl Cancer Inst 1989 0.78
155 The Csk-like proteins Lsk, Hyl, and Matk represent the same Csk homologous kinase (Chk) and are regulated by stem cell factor in the megakaryoblastic cell line MO7e. Growth Factors 1997 0.78
156 Mechanism of target cell recognition by CD3- LGL. I. Development of a monoclonal antibody to a K562-associated target cell antigen. Cell Immunol 1992 0.78
157 Phenotypic and functional characterization of a panel of cytotoxic murine NK cell clones that are heterogeneous in their enhancement of Ig secretion in vitro. Int Immunol 1998 0.78
158 Mechanisms of cytotoxicity used by human peripheral blood CD4+ and CD8+ T cell subsets. The role of granule exocytosis. J Immunol 1993 0.78
159 Involvement of the 2'-5' A pathway in the augmentation of natural killer activity. Nat Immun Cell Growth Regul 1987 0.78
160 Analysis of a cytostatic lymphokine produced by incubation of lymphocytes with tumor cells: relationship to leukoregulin and distinction from recombinant lymphotoxin, recombinant tumor necrosis factor, and natural killer cytotoxic factor. J Immunol 1986 0.78
161 Cytotoxicity by natural killer cells: analysis of large granular lymphocytes. Methods Enzymol 1986 0.77
162 Interferon and natural killer (NK) cells. Tex Rep Biol Med 1983 0.77
163 Association of the expression of an SR-cyclophilin with myeloid cell differentiation. Blood 1996 0.77
164 Augmentation of human natural killer cell activity by interferon: conditions required for boosting and characteristics of the effector cells. J Interferon Res 1981 0.77
165 Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells. Nat Immun Cell Growth Regul 1985 0.77
166 Alpha-interferon structure and natural killer cell stimulatory activity. Cancer Res 1990 0.77
167 Regulation of large granular lymphocytes and human T cell growth and function by recombinant interleukin 2. II. Acquisition of potent cytotoxic capabilities. J Leukoc Biol 1987 0.77
168 Localization of a novel natural killer triggering receptor locus to human chromosome 3p23-p21 and mouse chromosome 9. Genomics 1993 0.77
169 The proliferation and function of human mononuclear leukocytes and natural killer cells in serum-free medium. J Immunol Methods 1985 0.77
170 Selective loss of NK cytotoxicity in antisense NK-TR1 rat LGL cell lines. Abrogation of antibody-independent tumor and virus-infected target cell killing. J Immunol 1995 0.77
171 CD3+, CD56+ non-MHC restricted cytotoxic T lymphocytes in two fraternal AIDS patients: a case report. Cytometry 1994 0.76
172 Assay of augmentation of natural killer cell activity and antibody-dependent cell-mediated cytotoxicity by interferon. Methods Enzymol 1981 0.76
173 CD3 negative "small agranular lymphocytes" are natural killer cells. J Immunol 1991 0.76
174 Methylation patterns of the T cell receptor beta-chain gene in T cells, large granular lymphocytes, B cells, and monocytes. J Immunol 1988 0.76
175 Characterization of human large granular lymphocyte subpopulations: comparison of the phenotype of NK cells and of interleukin 2-dependent progenitors of cytolytic effector cells. Nat Immun Cell Growth Regul 1985 0.76
176 Comparative evaluation of multiple lymphoid and recombinant human interleukin-2 preparations. J Biol Response Mod 1986 0.76
177 Implications of potential positive correlation between autologous tumor-cell-killing activity and prognosis in lung cancer. J Natl Cancer Inst 1990 0.75
178 Killer T's, macrophages, and NK's. The Fourth International Cell-Mediated Cytotoxicity Workshop, sponsored by the Pittsburgh CancerInstitute, and the University of Pittsburgh Medical Health Care Division, Oglebay Park, WV, USA, June 10-13, 1990. New Biol 1990 0.75
179 Analysis of rat natural killer cytotoxic factor (NKCF): mechanism of action and relationship to other cytotoxic/cytostatic factors. Cell Immunol 1991 0.75
180 Preparation of target antigens specifically recognized by human natural killer cells. Nat Immun Cell Growth Regul 1986 0.75
181 Natural killer activity: the definition of a function rather than a cell type. Immunol Today 1987 0.75
182 Adoptive immunotherapy involving recombinant human M-CSF and R24 anti-melanoma antibody induces human T-cell infiltration into human melanoma xenografts. J Immunother Emphasis Tumor Immunol 1996 0.75
183 Serologic analysis of the antigenic specificities of simian virus 40-transformed cells and their relationship to tumor-associated transplantation antigen. J Natl Cancer Inst 1974 0.75
184 Trichinella spiralis and Schistosoma mansoni: specificity of in vitro, leukocyte-mediated histamine release from rabbit platelets. Exp Parasitol 1971 0.75
185 Quantitative analysis of rod-cored vesicles and dense granules of large granular lymphocytes in the liver, spleen, and peripheral blood of rats. Cell Tissue Res 1994 0.75
186 Quantitative hemagglutination inhibition studies of blood-group substances. 3. Change in character of human anti-A hemagglutinins following immunization with blood-group A substance. Transfusion 1971 0.75
187 Responses of human large granular lymphocytes and classical T-cells in culture to allogeneic cells, lectins, and soluble antigen. J Leukoc Biol 1984 0.75
188 Specificity and phenotype of IL-2 expanded clones of human large granular lymphocytes. Diagn Immunol 1983 0.75
189 Differential basal protein tyrosine phosphorylation in natural killer (NK) and T cells: a biochemical correlate of lymphoid functional activity. Cell Immunol 1996 0.75
190 Cytotoxic activity of normal and Herpesvirus saimiri-transformed nonhuman primate cells. Cell Immunol 1985 0.75
191 Differentiation and function of natural killer cells. Nihon Ketsueki Gakkai Zasshi 1985 0.75
192 Changes in immune function in patients receiving natural leukocyte interferon. J Biol Response Mod 1983 0.75
193 In vitro proliferation of human large granular lymphocytes with v-raf/v-myc recombinant retrovirus. Experientia 1988 0.75
194 Differential regulation of interleukin-1 gene expression in human CD3- large granular lymphocytes. Cell Immunol 1990 0.75